- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
SoftBank finds Better option for $500m investment
The transaction hiked the onine mortgage platform developer's valuation 50% to $6bn in five months as it begins to prepare for an initial public offering.
Apr 12, 2021Anjuke advances to IPO stage
The property service platform is set to list in Hong Kong, handing exits to 58.com, Agile, Chinachem, CSC Land, Country Garden, Henderson, NWD, SHKP, Tencent and Times Property.
Apr 12, 2021Battery Resourcers charges up with $20m
Orbia Ventures led a round for the battery production technology provider that included TDK Ventures, Trumpf Venture, Doral Energy-Tech Ventures and InMotion Ventures.
Apr 12, 2021Vaccitech shoots for US IPO
Alphabet, Tencent and Gilead Sciences are in line to achieve exits, after the vaccine developer filed to go public on the Nasdaq Global Market.
Apr 12, 2021Artiva activates $100m IPO plans
The NK cancer drug provider has filed to go public in an offering which would enable GC and its GC Labcell subsidiary to exit.
Apr 12, 2021Hologic hoists in Mobidiag
Autobio Diagnostics is set to exit the molecular diagnostic test provider through a purchase by women’s health-focused technology provider Hologic.
Apr 12, 2021Salesforce joins Community with $40m investment
Salesforce has supplied additional funding for the text messaging platform operator, which is also backed by Sony, Live Nation and Twilio.
Apr 12, 2021Snorkel AI pipes in $35m
GV returned for a series B round that increased the machine learning technology developer's overall funding to $50m.
Apr 12, 2021Schroders shifts Carrick stake at discount
Schroder UK Public Private Trust, the rebranded fund previously led by Neil Woodford, has sold its shareholding in Carrick Therapeutics at a discount.
Apr 12, 2021IceKredit gets series C2 funding
The Youzu Interactive-backed credit rating services provider has collected $34.8m in a series C2 round led by CDB-CDC Capital.
Apr 12, 2021Oxford Endovascular enters series A stage
University of Oxford, OSI and Parkwalk Advisors all returned for Oxford Endovascular’s $10m series A round.
Apr 12, 2021Vaccitech shoots for US IPO
Oxford spinout Vaccitech, which developed the technology underlying the university’s covid vaccine, has filed for an offering on the Nasdaq Global Market.
Apr 12, 2021Featured Content
GCV Powerlist 2026Nominations for the 2026 GCV Powerlist are now open. Use this form to nominate yourself or someone else.GCV Powerlist 2026
Nominations for the 2026 GCV Powerlist are now open. Use this form to nominate yourself or someone else.
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation


